Zhang Yuli – Trademark Portfolio
Entity Type: 01
Zhang Yuli owns a portfolio of 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as AMYONE, RNGMSI, DEXAGUKE, JADEKENG, and XBELMBER. Of these, 6 are registered. The portfolio spans 6 Nice Classification classes, led by Class 35 (Advertising & Business) and Class 25 (Clothing). Headquartered in Ningde, Fujian.
No.72, Xincuo Xia, Tangkou Village
Tangkou Township, Pingnan County
Ningde, Fujian 352300 , CN
Showing of trademarks Trademarks
Trademark Classifications
Zhang Yuli's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Precious metals and their alloys; jewellery, precious stones; horological instruments
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does Zhang Yuli have?
Zhang Yuli has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.
What trademark classes does Zhang Yuli file in?
Zhang Yuli files trademarks across 6 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 25 (Clothing), Class 9 (Computers & Electronics), Class 21 (Housewares), Class 14 (Jewelry). Class 35 covers advertising; business management; business administration; office functions.
What are Zhang Yuli's most well-known trademarks?
Zhang Yuli's registered trademark portfolio includes well-known marks such as AMYONE, RNGMSI, DEXAGUKE, JADEKENG, and XBELMBER. These are among 6 currently registered trademarks in the portfolio.
What is Zhang Yuli's trademark registration success rate?
Zhang Yuli has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.